In connection with this acquisition, Milestone has also agreed to terminate its declaratory judgment action against Milton Hodosh related to claimed infringements of his patent rights and Dr Hodosh has agreed to terminate his existing infringement action against the company. Each party is responsible for their own attorney fees.
Joe Martin, CEO of Milestone, said: “We are pleased to have acquired these additional patent rights, which strengthen our position as the dominant leader of advanced technology for administering painless anesthetic injections without expending any of our cash resources. Also, the related settlement of our declaratory judgment action against Dr Hodosh and his infringement action against us eliminates further legal expense.”